69 Best Biotech Startups in France to Watch in 2024

Vonafexor drug maker for the treatment of Alport syndrome.

Total Raised: $110.47M

Last Funding: $42.57M (Series C)

Developer of MEM-ANT3310, a next generation antibacterial combination.

Total Raised: $35.86M

Last Funding: $1.00M (Seed)

Brenus Pharma is a cancer vaccine developer founded in 2021 by Benoit Pinteur.

Total Raised: $29.50M

Last Funding: $25.00M (Series A)

Animal-free dairy protein.

Total Raised: $20.15M

Last Funding: $4.20M (Seed)

Interceptive therapies for heart failure subpopulations.

Total Raised: $82.41M

Last Funding: $69.61M (Series A)

Gene-editing platform.

Total Raised: $50.83M

Last Funding: $18.00M (Series A)

Peptides for the treatment of rare endocrine and related diseases.

Total Raised: $138.63M

Last Funding: $138.63M (Series C)

Preclinical biotech company developing technology for the treatment of eye diseases.

Total Raised: $7.00M

Last Funding: $7.00M (Seed)

International advisory firm for healthcare sector.

Total Raised: $93.00M

Last Funding: $58.00M (Series C)

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

Total Raised: $127.76M

Last Funding: $15.90M (Series C)

Technology to transform human urine into an alternative to agricultural fertilizer.

Total Raised: $11.89M

Last Funding: $0.10M (Seed)

MRI plug-and-play solution developer for veterinary use.

Total Raised: $5.46M

Last Funding: $5.46M (Series A)

Medical devices for a transvascular treatment of pulmonary hypertension.

Total Raised: $14.99M

Last Funding: $14.99M (Series A)

Biomanufacturer of complex molecules.

Total Raised: $4.31M

Last Funding: $4.31M (Seed)

Regenerative diabetes treatment.

Total Raised: $30.15M

Last Funding: $30.15M (Series A)

Niodegradable sealants and adhesives for wound closure.

Total Raised: $163.52M

Last Funding: $55.00M (Series C)

Therapeutic treatment for hearing loss disorders.

Total Raised: $38.28M

Last Funding: $38.28M (Series B)

Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).

Total Raised: $59.73M

Last Funding: $15.80M (Series A)

Protein-based vaccines.

Total Raised: $7.84M

Last Funding: $7.84M (Series A)

Biotechnology company developing advanced cancer treatments.

Total Raised: $34.92M

Last Funding: $30.14M (Series A)

InnovaFeed SAS is a French biotechnology company that develops large-scale insect breeding and processing processes. It sells ingredients derived from insects for animal nutrition and aquaculture.

Total Raised: $250.15M

Last Funding: $250.15M (Series D)

Platform developing new treatments that focus on the butyrophilin family's checkpoint molecules.

Total Raised: $102.30M

Last Funding: $102.30M (Unknown)

Treatment for brain cancer.

Total Raised: $2.20M

Last Funding: $2.20M (Seed)

Tumor immunity reserch.

Total Raised: $4.73M

Last Funding: $4.73M (Seed)

Breast milk producer from cell-cultured mammary glands.

Total Raised: $3.21M

Last Funding: $3.21M (Pre Seed)

Stem cell company enabling access to cell therapies for millions of patients.

Total Raised: $82.33M

Last Funding: $75.05M (Unknown)

Houseplants developer to remove harmful air pollutants.

Total Raised: $20.00M

Last Funding: $20.00M (Seed)

SeqOne is a next generation genomic analysis for next generation healthcare.

Total Raised: $26.11M

Last Funding: $22.72M (Series A)

PCOS infertility treatment developer.

Total Raised: $35.80M

Last Funding: $25.00M (Series B)

AI-driven high-dimensional immune system analysis platform.

Total Raised: $10.72M

Last Funding: $8.12M (Seed)

Biotechnology platform developing advanced recombinant protein production technologies.

Total Raised: $14.16M

Last Funding: $11.01M (Series A)

Therapeutic platform focused on developing treatments that promote immune tolerance.

Total Raised: $32.13M

Last Funding: $29.16M (Series A)

Platform that uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.

Total Raised: $5.95M

Last Funding: $5.95M (Series A)

Biotechnology firm focused on life science advancements.

Total Raised: $89.62M

Last Funding: $89.62M (Series A)

Provider of minimally invasive solutions for treatment of tricuspid regurgitation

Total Raised: $50.00M

Last Funding: $50.00M (Series D)

Platform to treat moderate to severe dysbiosis in patients.

Total Raised: $42.23M

Last Funding: $1.00M (Seed)

Medical device company that develops systems to help manage diabetes automatically.

Total Raised: $73.92M

Last Funding: $73.92M (Unknown)

Gene therapies for rare diseases.

Total Raised: $25.79M

Last Funding: $4.40M (Series A)

Biotech firm developing treatments for auto-immune diseases.

Total Raised: $6.04M

Last Funding: $6.04M (Series A)

Developer of a universal AI foundation model for biology.

Total Raised: $35.00M

Last Funding: $35.00M (Seed)

Platform biotechnology company focused on developing therapies for rare skeletal diseases.

Total Raised: $24.41M

Last Funding: $24.41M (Series A)

Topical treatments for complex pain.

Total Raised: $21.38M

Last Funding: $21.38M (Series B)

Drug discovery platform.

Total Raised: $43.79M

Last Funding: $32.48M (Series A)

Platform for gene and cell therapy companies to develop cheaper drugs faster using digital tools.

Total Raised: $10.50M

Last Funding: $10.00M (Seed)

Petroleum-free pigments.

Total Raised: $20.51M

Last Funding: $15.80M (Series A)

Eco-friendly liquid-liquid direct lithium extraction (DLE) process developer.

Total Raised: $35.48M

Last Funding: $27.00M (Series B)

Platform for horticulture LED lighting systems, photobiology research, and indoor and greenhouse lighting.

Total Raised: $21.60M

Last Funding: $18.62M (Series A)

Biotech solution providing NGS-based metagenomic tests to fully identify pathogens.

Total Raised: $26.12M

Last Funding: $17.31M (Series B)

AI-powered data collecting tool for clinical trials.

Total Raised: $21.60M

Last Funding: $20.00M (Series A)

Developer of biotherapeutic products to treat cancer.

Total Raised: $9.00M

Last Funding: $5.30M (Series A)

Platform creating lab-grown alternatives to animal leather using synthetic biology and material science.

Total Raised: $7.67M

Last Funding: $4.66M (Unknown)

Biocontrol solutions company that develops new methods for agriculture.

Total Raised: $6.07M

Last Funding: $4.96M (Unknown)

Biotechnology firm developing immunotherapies for cancer and autoimmune diseases.

Total Raised: $46.22M

Last Funding: $46.22M (Unknown)

Imaging technology for quick and non-invasive skin cancer detection.

Total Raised: $5.67M

Last Funding: $5.67M (Series A)

Genetic analysis technology for decoding the dynamic genome.

Total Raised: $35.40M

Last Funding: $35.40M (Series A)

Platform that develops bio factories to treat significant eye diseases sustainably.

Total Raised: $30.00M

Last Funding: $30.00M (Series B)

Platform that accelerates drug discovery using advanced computational techniques.

Total Raised: $17.23M

Last Funding: $17.23M (Seed)

AI-dirven clinical biology.

Total Raised: $14.96M

Last Funding: $14.96M (Series A)

Developer of innovative curative therapies.

Total Raised: $16.07M

Last Funding: $16.07M (Series A)

Personalised therapeutic vaccine developer for colorectal cancer.

Total Raised: $8.70M

Last Funding: $8.70M (Series B)

Digital platform developing therapeutic solutions with advanced technologies.

Total Raised: $3.63M

Last Funding: $3.63M (Seed)

Developer of therapeutic molecules to treat cancer.

Total Raised: $8.24M

Last Funding: $8.24M (Series A)

3D bioprinting technology for regenerative medicine.

Total Raised: $6.34M

Last Funding: $6.34M (Unknown)

Therapeutic tools for treating cancer.

Total Raised: $5.71M

Last Funding: $5.71M (Series A)

Biopharmaceutical company focused on developing Rapid Transfer Systems (RTS) solutions.

Total Raised: $4.39M

Last Funding: $1.01M (Series B)

Biotech firm specializing in the production of rapid biosensing devices like the CHRONOS PCR.

Total Raised: $7.81M

Last Funding: $5.49M (Unknown)

Natural algae-based products supporting weight loss and brain health research, development, and production.

Total Raised: $15.57M

Last Funding: $15.57M (Unknown)

Developing pinpoint gene therapy.

Total Raised: $5.57M

Last Funding: $5.57M (Series A)

Biotechnology firm creating peptide-based vectors to improve drug and imaging agent delivery to the brain.

Total Raised: $7.89M

Last Funding: $7.89M (Series D)